PARICALCITOL
Substance profile for UNII 6702D36OG5, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 5281104Substance Identity#
- UNII
- 6702D36OG5
- Preferred term
- PARICALCITOL
- Registry number
- 131918-61-1
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C27H44O3
Structure render from PubChem CID 5281104Chemical And Database Identifiers#
- InChIKey
- BPKAHTKRCLCHEA-UBFJEZKGSA-N
- SMILES
- C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]2[C@]1(C)CCC\C2=C/C=C3C[C@@H](O)C[C@H](O)C3
- RxCUI
- 73710
- PubChem
- 5281104
- NCIt
- C38693
- INN ID
- 7688
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998 | 2 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998 | 2 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998 | 8 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998 | 8 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | ZEMPLAR (PARICALCITOL) INJECTION, SOLUTION [ABBVIE INC.] | 1439 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | ZEMPLAR (PARICALCITOL) INJECTION, SOLUTION [ABBVIE INC.] | 1439 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | ZEMPLAR (PARICALCITOL) CAPSULE, LIQUID FILLED [ABBVIE INC.] | 1438 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | ZEMPLAR (PARICALCITOL) CAPSULE, LIQUID FILLED [ABBVIE INC.] | 1438 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [ZYDUS PHARMACEUTICALS USA INC] | 26 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [ZYDUS PHARMACEUTICALS USA INC] | 26 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [DR. REDDY'S LABORATORIES LIMITED] | 7 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [DR. REDDY'S LABORATORIES LIMITED] | 7 | |
| paricalcitol | ACTIVE INGREDIENT | 6702D36OG5 | ZEMPLAR (PARICALCITOL) CAPSULE, LIQUID FILLED [CARDINAL HEALTH] | 6 | |
| paricalcitol | ACTIVE MOIETY | 6702D36OG5 | ZEMPLAR (PARICALCITOL) CAPSULE, LIQUID FILLED [CARDINAL HEALTH] | 6 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [AMERICAN HEALTH PACKAGING] | 3 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [AMERICAN HEALTH PACKAGING] | 3 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 3 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [TEVA PHARMACEUTICALS USA INC] | 3 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, GELATIN COATED [RISING PHARMACEUTICALS, INC.] | 1 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, GELATIN COATED [RISING PHARMACEUTICALS, INC.] | 1 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL CAPSULE, LIQUID FILLED [GOLDEN STATE MEDICAL SUPPLY, INC.] | 1 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| PARICALCITOL | ACTIVE INGREDIENT | 6702D36OG5 | PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| PARICALCITOL | ACTIVE MOIETY | 6702D36OG5 | PARICALCITOL INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |